Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient.

Agrati, Chiara; Castilletti, Concetta; Sacchi, Alessandra; Colavita, Francesca; Capobianchi, Maria Rosaria; Puro, Vincenzo; Nicastri, Emanuele; Ippolito, Giuseppe; Bibas, Michele

Agrati, Chiara; Castilletti, Concetta; Sacchi, Alessandra; Colavita, Francesca; Capobianchi, Maria Rosaria; Puro, Vincenzo; Nicastri, Emanuele; Ippolito, Giuseppe; Bibas, Michele.

Agrati C; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Castilletti C; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Sacchi A; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Colavita F; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Capobianchi MR; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Puro V; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Nicastri E; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Ippolito G; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.
Bibas M; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCSS, Rome, Italy.

J Cell Mol Med ; 2021 May 25.

Article in English | MEDLINE | ID: covidwho-1242168

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal subject: Molecular Biology Year: 2021 Document Type: Article Affiliation country: Jcmm.16565

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google